![]() |
Volumn 77, Issue 2, 1994, Pages 175-178
|
Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
B 581;
BZA 5B;
CYCLIC GMP PHOSPHODIESTERASE;
CYTOSTATIC AGENT;
DIMETHYLALLYLTRANSFERASE;
FARNESYL TRANS TRANSFERASE;
GUANINE NUCLEOTIDE BINDING PROTEIN;
L 731734;
MANUMYCIN;
PHOSPHORYLASE KINASE;
PRODRUG;
PROTEIN FARNESYLTRANSFERASE INHIBITOR;
RAS PROTEIN;
SQUALENE SYNTHASE;
TRANSDUCIN;
TRANSFERASE INHIBITOR;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
CANCER INHIBITION;
CELL TRANSFORMATION;
COLON CANCER;
DRUG CYTOTOXICITY;
DRUG EFFICACY;
GENE MUTATION;
HUMAN;
NONHUMAN;
ONCOGENE RAS;
PANCREAS CANCER;
PRIORITY JOURNAL;
PROTEIN PROCESSING;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
|
EID: 0028331587
PISSN: 00928674
EISSN: None
Source Type: Journal
DOI: 10.1016/0092-8674(94)90308-5 Document Type: Short Survey |
Times cited : (513)
|
References (26)
|